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ABSTRACT 
 
Objectives: To assess post-operative patient comfort and graft success following 
conjunctival autografts with sutures compared with Tisseel glue for pterygium surgery, and 
to identify which procedure was the more cost-effective surgical option. 
Design and Methods: A prospective randomized comparison of 60 patients undergoing  
primary pterygium surgery at St John Eye Hospital between April 2012 and September 
2012. A post-operative comfort scale was used to assess foreign body sensation, sensitivity 
to light, tearing and itchiness. Graft success was defined as a graft that was still adherent at 
one month following surgery. 
Results: Patients in the Tisseel glue group experienced significantly less foreign body 
sensation (p=0.038) and itchiness (p=0.018) on day-one after surgery, compared to those in 
the suture group. At one-month follow-up patients had significantly less foreign body 
sensation (p=0.042), sensitivity to light (p=0.001), and itchiness (p=0.009) in the Tisseel 
glue group compared to the suture group. Autograft adherence was seen in all 60 patients 
at the one-month follow-up visit. Both the surgical time and the indirect costs of the 
procedure were reduced in the Tisseel glue group.  
Conclusions: The use of Tisseel glue for attaching autografts in pterygium surgery is an 
effective method with global autograft success, less post-operative discomfort and shorter 
operating times.  
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CHAPTER 1  
	  
This chapter addresses the research question and aims, its importance and the justification 
for the study. A brief background of the topic is described, as well as a literature review on 
the important points regarding this condition and existing research in the field.  
 INTRODUCTION 
A pterygium is a triangular-shaped conjunctival growth that extends onto the cornea, and is 
usually located nasally.1 Surgery is commonly used to treat this condition. Pterygium 
surgery involves excision of the pterygium, and the harvesting of a conjunctival graft from 
the same eye, which is then placed over the defect. The graft, known as an autograft, is 
either sutured or opposed with fibrin glue. This study has assessed whether one technique 
is superior to the other when comparing the patient’s post-operative comfort and graft 
adherence. 
 
1.1 Problem Statement 
Pterygium surgery utilizes extensive operating theatre and outpatient resources. The use of 
a corneal adhesive rather than sutures might reduce theatre time and outpatient visits 
allowing this time to be better allocated to sight-saving surgery.  
 
1.2 Justification for The Study 
Patients with pterygia are frequently seen at St John Eye Hospital, in Soweto, South 
Africa; and they often require surgery. We currently follow a surgical technique that uses 
sutures to secure the graft. This is believed to cause significant patient discomfort post-
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operatively when compared to the alternative of using fibrin glue. This study has explored 
whether patients undergoing pterygium surgery at this institute experienced any significant 
differences in their levels of post-operative discomfort when comparing the two surgical 
techniques. 
 
1.3 Background and Literature Review 
1.3.1 Anatomy and Physiology 
The eye is composed of several layers – with the outermost layers consisting of the cornea 
and sclera and a conjunctival layer covering the sclera. The cornea is the most anterior 
portion of the globe; and it is responsible for refracting incoming light onto the back of the 
eye. The cornea is composed of five different layers: the outer epithelium; Bowman’s 
membrane; the stroma; Descemet’s membrane and the inner endothelium. The cornea is 
nourished, protected and kept moist by a constant tear film, which is distributed over the 
smooth regular surface of the cornea every time a person blinks. A pterygium is a 
conjunctival growth that extends from the nasal conjunctiva over the limbus and onto the 
cornea.1,2 As a pterygium grows towards the centre of the cornea (visual axis), it may 
interfere with the tear-film stability of the eye resulting in a dry eye.3 Pterygia may 
compromise a patient’s vision by growing into the visual axis of the cornea or by altering 
the curvature of the cornea (astigmatism), thereby affecting the refraction of light onto the 
back of the eye.4 
 
1.3.2 Pathogenesis and Clinical Features 
The aetiology of pterygia has intrigued researchers for centuries. It appears that a 
“pterygium belt” of 37 degrees latitude either side of the equator highlights areas with 
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higher prevalence rates of pterygia.2,5 In these hot climates, patients are exposed to chronic 
dryness, ultraviolet (UV) radiation, wind and dust, all of which seem to play a role in the 
development of pytergia.1-3,6,7 Research shows that chronic (UV) B radiation may induce 
cellular changes at the nasal limbus, the area of the eye most likely to be a focal point of 
any incoming light.2,6,7 
Population-based studies show independent associations of pterygium prevalence, and 
these include living in rural areas, increasing age, male sex and outdoor work.2,4,5,6,7 A 
hereditary influence on pterygium formation has also been recognized; and a possible 
genetic predisposition has been reported in both white and black Africans.8,9  
Several classifications for pterygia exist – ranging from how fleshy and injected the lesion 
is – to how far it extends onto the cornea. For the purpose of this study, pterygia will be 
classified clinically as grade 1, 2 or 3 based on the size of the pterygium. This system was 
adapted from an article by Popat et al.10 
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Table 1.1 Clinical grading system of pterygia and associated complications10 
Grade Extent Complications 
I <2mm onto the cornea Usually asymptomatic. 
Occasionally becomes red, 
inflamed and uncomfortable.  
II 2-4mm onto the cornea Distorts the corneal topography. 
Induces with or against the rule of 
astigmatism.4,10 
Often inflamed. 
III >4mm onto the cornea Involves the visual axis.4,10 
Can extend into the conjunctival 
fornices and limit ocular motility. 
 
1.3.3 Management  
Although topical anti-inflammatory and lubricant drops may temporarily reduce the 
redness and patient discomfort, surgical excision appears to be the treatment of choice for 
pterygia.11 The indications for surgery include visual impairment and the restriction of 
ocular movements, chronic inflammation and discomfort, and also for cosmetic reasons.11 
Surgery should also be considered in pterygia with an unusual appearance, as they may 
represent a masquerading condition, such as malignancy.11 
Several surgical techniques are recognized in the treatment of pterygia. Techniques, such 
as the simple excision leaving bare sclera, or excision and primary closure with 
conjunctival sutures; but these are seldom used because of high recurrence rates.  
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Bare Scleral Closure: “Bare scleral closure as a technique generally implies the removal 
of the pterygium with excision of some of the bulbar conjunctiva nasally, leaving the 
defect to heal from the surrounding conjunctiva. Occasionally, the conjunctiva may be 
sutured to the sclera; while at other times, the conjunctiva is left free to adhere to the 
underlying sclera”.11 Although this is one of the older surgical options, bare scleral closure 
is commonly used in conjunction with adjunctive therapy, including mitomycin, beta-
irradiation, and thiotepa.11  
Bare scleral closure without adjunctive therapy is by far the fastest method of removal; and 
it requires minimal skill; however, the disadvantage is the unacceptably high recurrence 
rates of 11% to 80%.11,12 
 
Simple Conjunctival Closure: There is a paucity of literature regarding this technique. It 
involves a conservative pterygium tissue excision, and then apposition of the remaining 
conjunctiva with sutures to cover the sclera.11 This technique appears not to be very 
promising, as recurrence rates range from 45% to 70%.11 
 
Sliding Conjunctival Flaps: Many texts describe the use of a sliding conjunctival graft 
after pterygium excision, using either the inferior or superior conjunctiva. The merits 
include the flap maintaining its original blood supply with minimal complications.11 
 
Conjunctival Autograft: This technique gained popularity in the 1980s; and involves the 
excision of the pterygium, leaving a small area of bare sclera, which is closed by using a 
free conjunctival graft from another area of the bulbar conjunctiva.11,14 Several prospective 
studies have looked at the rates of recurrence using this technique; and they show results as 
low as 2%.11 This method of surgery attempts to reconstruct the normal anatomy of the 
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limbus, resulting in a better cosmetic outcome, and lower rates of recurrence, compared 
with other techniques.11  
Traditionally, the graft would be fixed using sutures, which requires a high degree of 
surgical expertise and carries the risk of suture-related complications, such as suture 
granulomas (mass of granulation tissue), abscess formation, tissue necrosis (cell death) and 
giant papillary conjunctivitis.13 Other disadvantages include prolonged surgery time and 
post operative foreign body sensation and discomfort.13,14  
 An upregulation in the inflammatory response around vicryl sutures in the conjunctiva 
seems to be responsible for these adverse events;15  therefore, by replacing sutures with 
fibrin glue it might be expected that the graft would adhere; and the post-operative 
discomfort and other complications associated with the suture material might be alleviated.  
The use of Tisseel fibrin glue in pterygium surgery was first reported in 1993 by Cohen 
and McDonald.16 Nieuwendaal et al. in 2006 described replacing absorbable sutures with 
fibrin glue to attach conjunctival autografts during pterygium surgery.17 Tisseel fibrin glue 
(Baxter, USA) is a two-component fibrin sealer, which when combined has haemostatic, 
adhesive, sealant and wound-support properties.18 It seems reasonable to try to replace the 
sutures with an adhesive (fibrin glue) that can be applied to the surface of the eye – not 
only to secure the graft – but to limit the patient’s discomfort. 
Recently, Srinivasan et al. completed a prospective observer-masked clinical trial, showing 
that conjunctival grafts secured with fibrin glue are as stable as those secured with sutures 
and they also produced significantly less inflammation.19 Bahar et al. utilized a self-report 
questionnaire to compare the level of patient discomfort following pterygium surgery when 
using either fibrin glue or sutures. They found a significantly lower score for patient 
	   	  7	  
discomfort and pain in the fibrin group.20 The symptoms reported on included: average 
pain, sensitivity to light, foreign body sensation, irritation, tearing, itching and redness.20 
This study also showed that operating times were reduced, when using the glue; and that 
patients in the fibrin group reported far better overall satisfaction than those in the suture 
group.20 These outcomes had an impact on the success of pterygium surgery; and they 
were beneficial to both patient and doctor.20 
Adjunctive Therapy: Mitomycin C, beta irradiation, and thiotepa are considered as 
principal medical adjunctive therapies in pterygium surgery to prevent recurrence.11,21 
Recently, the use of bevacizumab intra-operatively as an adjunctive has also been 
described.22 
Beta-irradiation has been used predominantly for several years after bare sclera removal; 
but the outcomes of this adjunctive therapy have, unfortunately, been poorly reported in 
the literature. Complications following beta radiation, although rare, do exist. These 
include corneal or scleral melting and endophthalmitis, complications, which probably 
would not warrant its use in a disease, such as pterygium.23 
Thiotepa is another adjunctive administered – usually after bare sclera closure – in the 
form of topical drops for approximately six weeks.11 This therapy has been used for about 
as long as beta-irradiation; and it is also poorly reported on in the literature.  
Mitomycin C is commonly used in pterygium surgery, both intra- and post-operatively.21 
The main objective with pterygium surgery is to prevent recurrence, which autologous free 
grafts and concurrent mitomycin C seem to promise.21 A dose of 0.02% is applied for 
between 2.5 minutes to 3 minutes during surgery, usually when employing the bare sclera 
closure or conjunctival closure techniques.11,21,24 The recurrence rates with intra-operative 
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mitomycin C appear to be low. A study looking at the long-term follow-up of low-dose 
intra-operative mitomycin C, compared to conjunctival autografts, showed recurrence rates 
of 14.3% and 5%, respectively.24 
Other studies report 3% to 39.7% recurrence rates with the use of intra-operative 
mitomycin C.21 Complications of the use of both intra-operative and post-operative 
mitomycin C with bare sclera and conjunctival closure techniques include scleral 
ulceration and delayed conjunctival epithelialization.25 Higher rates of complications are 
seen with longer exposure times and increased concentrations of mitomycin C.25 
Post-operative dosages of mitomycin C are still under debate; while we await studies, 
which report on the long-term follow-up of these patients. A dose of 0.02% daily for two 
weeks appears to have favourable outcomes showing low recurrence rates.11 
The American Academy of Ophthalmology recently reported on a literature review of 51 
studies with at least 6 months follow-up times, describing the options and the adjunctives 
in pterygium surgery.25  Bare sclera excision had higher recurrence rates than the same 
technique with adjunctive therapy.25 Autografts had lower recurrence rates than amniotic 
membrane grafts.25 The addition of mitomycin C, combined with autografts, further 
reduced the risk of recurrence of pterygia, when compared to the use of mitomycin C 
alone, or an autograft without mitomycin C.25 
A novel approach of using the patient’s own blood (autologous blood) to fixate the graft 
has been suggested in the literature. This would mean no glue and no sutures; and this 
technique carries several cost and comfort advantages. However, randomized control trials 
have not been performed as yet.26 
	   	  9	  
1.3.4 Cost-Effectiveness 
The term cost-effectiveness is very often confused with monetary costs; but rather it 
compares the costs and health effects of an intervention to assess the extent to which it can 
be regarded as providing value for money.27 Analysing the cost-effectiveness of a product 
or procedure allows decision-makers to determine where to allocate limited healthcare 
resources.27 Uy et al. reported a significantly shorter operating time, a far less surgically 
challenging procedure, and a less expensive material, when using the glue instead of 
sutures.14 The variables above contribute to the cost-effectiveness of this procedure; and 
they need to be considered when embarking on pterygium surgery.  
 
Pterygia are a common occurrence; and they frequently require surgery. At our institution, 
sutures are used to secure the autograft. The use of suture material requires a high degree 
of surgical expertise; and it may lead to suture-related complications and post-operative 
eye discomfort. Eye discomfort or pain is typically divided into the following parameters: 
foreign body sensation, sensitivity to light, tearing and itchiness.14 In an attempt to 
alleviate this discomfort, and to provide patients with a less painful recovery – without 
compromising on autograft success – the use of a fibrin glue needed to be explored at our 
facility. 
 
1.4 Research Aim 
The aim of this study was to compare post-operative patient comfort and graft success 
following conjunctival autografts for pterygium surgery when using vicryl sutures 
compared to Tisseel fibrin glue.  
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1.5 Research Objectives 
The primary objective of this study was to compare vicryl sutures and Tisseel fibrin glue 
for autografts in pterygium surgery, and to establish whether there is any significant 
difference between the vicryl sutures and Tisseel glue, when assessing post-operative 
patient comfort and graft success. 
The secondary objective of this study was to identify whether Tisseel fibrin glue is a more 
cost-effective surgical option than the use of sutures. 
 
1.6 Hypothesis 
Tisseel fibrin glue used in pterygium excision surgery to secure the autograft would leave 
the patient more comfortable post-operatively, while still allowing for autograft adherence.  
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CHAPTER 2 
	  
This chapter will discuss the methodology of the study, including the study design, the 
study population, and the method and materials used for data collection. A description of 
the surgical procedure and post-operative management will be mentioned, followed by 
how the data analysis was completed. Both ethical considerations and the issue of the 
sponsorship of Tisseel fibrin glue will be addressed.  
METHODOLOGY 
2.1 Study Design 
This prospective randomized comparative study included 60 patients undergoing primary 
pterygium excision surgery at St John Eye Hospital, Soweto.  
 
2.2 Study Population 
Patients with pterygia were selected on presentation to the hospital and assigned a number. 
The patients were numbered from 1 to 60, in the order of presentation; odd numbers were 
assigned to the Tisseel glue group and even numbers to the suture group.  
Inclusion criteria:  
• Grade I, II and III pterygia;  
• Age >18 years of age;   
• No previous pterygium surgery.  
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Exclusion criteria:  
• Patients <18 years of age; 
• History of eye trauma or pseudo-pterygium; 
• Intra-ocular and local disease. 
 
2.3 Pre-operative Assessment 
A pre-operative interview was conducted to obtain a detailed history of the complaint. A 
slit lamp examination was performed to determine the pterygium size in millimetres, by 
measuring from the limbus to the corneal limit of the growth in the horizontal plane. The 
pterygium was to be graded as follows: Grade I pterygia extend less than 2mm onto the 
cornea; grade II pterygia extend 2mm to 4mm onto the cornea; and grade III pterygia 
extend more than 4mm onto the cornea.  
The patient was examined to exclude any ophthalmic infection, local or uncontrolled 
systemic disease or infection. 
 
2.4 Informed Consent 
Informed consent was obtained pre-operatively from all the eligible patients, and from all 
those who were willing to participate in the study. The standardized information sheet 
(Appendix A) and consent form (Appendix B) were printed in English. If necessary, a 
translator from the nursing staff assisted in obtaining this consent in the patient’s first 
language. Once the patient had agreed to be enrolled in the study, he/she was randomized 
into one of two groups, as mentioned above. The patients were not informed as to which 
group they belonged. 
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2.5 Tisseel Glue Preparation 
The Tisseel Kit 1.0ml (Baxter) was mixed by the same Ophthalmology registrar (LS) ten 
minutes prior to starting with the first surgical case. The following steps were carried out 
routinely: 
The Fibrinotherm heating device was turned on at the amber switch and allowed to heat up 
to a temperature of 37 degrees Celsius. 
 
Figure 2.1: The Fibrinotherm heating and mixing device 
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Four vials from the box; two blue-topped, one black-topped and one silver-topped vials 
(select Thrombin 4 not 500 for pterygium surgery), were placed in their wells, and allowed 
to heat for a few minutes.  
 
Figure 2.2: The different Tisseel Kit vials required for mixing 
 
 
Figure 2.3: The different vials in their respective heating and mixing wells 
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Once heated, the blue-scaled syringe was used to withdraw the entire volume of the 
fibrinolysis inhibitor (blue top) and injected into the sealer protein concentrate vial. 
 
Figure 2.4: Withdrawing the fibrinolysis inhibitor 
 
 
Figure 2.5: Injecting the fibrinolysis inhibitor into the sealer protein vial 
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This combination was placed into the stirring well; and the mixer was turned on at the 
green switch, allowing the solution to mix for 5 minutes to 15 minutes. 
 
Figure 2.6: Turning on the green switch to activate the magnetic stirring well 
 
During this time, the black scaled-syringe was used to withdraw the calcium chloride from 
the black-topped vial. This was then injected slowly into the thrombin 4 vial and swirled 
around gently, taking care not to invert the bottles at any time.  
 
Figure 2.7: Withdrawing the calcium chloride 
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Figure 2.8: Injecting the calcium chloride into the thrombin vial 
 
At this point, the duploject was opened for the scrub sister onto a sterile field, along with 
both black and blue-scaled syringes and their needles.  
The contents of the blue and black vials were separately aspirated with their respective 
blue and black syringes and loaded into the duploject.  
 
Figure 2.9: Assembly of the duploject 
	  
2.6 Surgical Procedure 
The operations were carried out by a senior ophthalmic surgeon (KA) and an 
ophthalmology registrar (LS) in the ophthalmology theatres at St John Eye Hospital, 
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Soweto. Peribulbar anaesthesia with bupivicaine 0.5% and a solution of lignocaine 2%, 
mixed with hyalase on the day of the surgery, was performed by the ophthalmology 
registrar. A drop of 5% povidone was instilled in the eye after the local anaesthesia had 
taken effect; and this was done to prevent any post-operative infections. The involved eye 
underwent standardized ophthalmologic sterile preparation and draping. 
 All pterygia excisions were performed under an operating microscope, with a lid 
speculum to expose the surgical site. The surgical time was recorded from placement of the 
lid speculum to its removal at the end of the procedure. The apex of the pterygium, which 
is the part that inserts onto the cornea, was dissected off the cornea up to the limbus – 
using a crescent blade, and taking care to maintain the surgical plane of the pterygium.  
Blunt dissection was performed to separate the remaining portion of the pterygium from 
the underlying sclera.  
The next step involved harvesting a free conjunctival autograft from the superior 
conjunctiva. The technique, as described by Starck et al, was used in this study.28 After 
measuring the defect with callipers, following the resection of the pterygium, an oversized 
graft, measuring at least 1mm (millimetre) greater than the measured area in both width 
and length, was marked out on the donor site with a sterile gentian violet marker pen. A 
balanced salt solution was injected, with a 2ml (millilitre) syringe and a 27 gauge needle, 
very superficially underneath the conjunctiva of the donor site. This was performed to 
separate this delicate structure from the underlying connective tissue, referred to as 
Tenon’s capsule.  
The marked out area was excised to create a free graft, which was then placed on the 
cornea, taking care not to flip it over; and it was kept moist by irrigating it with a balanced 
salt solution.  
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The free graft was placed over the bare sclera, keeping the orientation of the donor site, so 
that the graft’s limbal side would oppose the limbus, once it was secured.  Depending on 
which group the patient had been allocated to, the conjunctival edges of the graft would be 
sutured to the surrounding conjunctiva, or opposed with glue. The suturing involved four 
interrupted vicryl 8/0 sutures and only two single knots were tied on each suture, which 
were not buried. If glue was to be used, the preparation took place before the surgery; and 
the duploject device was used to apply the glue to the surgical site. 
The cannula on the duploject device allowed for placement of the solution on the bare 
sclera, and thereafter, the graft was positioned over the defect. The glue set in 60 seconds; 
and the graft’s adherence was ensured before removing the lid speculum. 
At the end of the procedure, a combination of a steroid /antibiotic ointment, 
dexamethasone and neomycin (Maxitrol), was applied to the surgical site, and an eye pad 
with tape (micropore) was used to cover the eye. This pad remained on the eye until the 
patient was assessed the following day.  
All excised pterygium specimens were placed in formalin, and sent to the laboratory for 
histological evaluation.  
 
2.7 Data Collection 
A data-capture sheet (Appendix C), which included an administrative section, 
demographics, clinical findings, surgery data and a questionnaire, was filed and kept 
confidential, using the patient’s unique study ID number. 
Intra-operative entries documented the name of the surgeon, the surgical time, the 
technique, the reference numbers for the sample sent to the lab, the post-operative 
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prescription and the follow-up dates. Following surgery, reviews took take place at day-
one, and months-one and three post-surgery. During the follow-up visits, several 
parameters, including patient comfort and graft integrity were assessed. Patients graded 
their discomfort, based on the following four categories: foreign body sensation, sensitivity 
to light, tearing and itchiness on an ordinal 4-point scale ranging from 1 to 4. 
Autograft success was defined as a graft that was still adherent by the first month follow-
up visit. It follows then that any autograft failure would refer to the dehiscence of the graft 
within the first month.  
 
2.8 Data Analysis 
The data was captured in Microsoft Excel 2011 and imported into IBM SPSS Version 20 
for further analysis. The first step in the analysis involved the construction of basic 
frequency and descriptive tables to examine any variations in the data. This predominantly 
involved inspection of proportions, means, medians, and standard deviations. A p-value of 
less than 0.05 was indicative of statistical significance during hypothesis testing. Patient 
comfort was analysed using the Mann-Whitney U test to assess any significant differences 
in the four dimensions of discomfort across the two surgical methods on day-one, one-
month, and three-months post-surgery.  
The Mann-Whitney U test is a suitable test when comparing ordinal data, of two non-
parametric variables; and it compares the mean ranking of groups. In essence, the scores of 
the level of discomfort for each group was converted to ranks and the mean rank for each 
group was then compared. The Kruskal-Wallis test was also utilized for comparing the 
ordinal data of three or more non-parametric variables. The Chi-Square test of 
independence was used to assess if proportional distributions were independent across the 
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categorical variables, such as recurrence rates in the two different surgical groups, 
recurrence and age, and recurrence and grade of the pterygium. 
In the event of few, sparse or unbalanced data, the Fischers Exact test, Monte Carlo 
Method tests and odd ratios were included. 
 
2.9 Ethical Considerations 
Ethical approval was attained from the Human Research Ethics Committee (Medical) of 
the University of the Witwatersrand (Appendix D); and permission was obtained from the 
Medical Advisory Committee Chris Hani Baragwanath Academic Hospital (Appendix E) 
before starting this project. Tisseel fibrin glue is registered with the Medical Control 
Council (Appendix F) as a blood fraction, which is used to achieve haemostasis, to seal or 
glue tissues, and to support wound healing.  
 
2.10 Sponsorship 
Adcock Ingram Pharmaceuticals provided the sponsorship of Tisseel fibrin glue and the 
fibrinotherm mixing device for the duration of this study (Appendix G). 
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CHAPTER 3 
RESULTS 
During the period from April 2012 to September 2012, 60 patients were recruited for the 
study and underwent pterygium surgery at St John Eye Hospital, Chris Hani Baragwanath 
Academic Hospital, Soweto.  
 
3.1 Patient Demographics 
Sixty patients, with a median age of 50 years, were enrolled in the study. Forty-two (70%) 
were female, 18 (30%) were male and 56 (93.3%) were black African patients. 
 
3.2 Patient Comfort 
3.2.1 Tisseel glue compared to sutures  
Patients rated their level of discomfort following surgery on a scale of 1 to 4 for foreign 
body sensation, sensitivity to light, tearing and itchiness, with 1 being indicative of no 
discomfort, 2 reflecting mild discomfort, 3 for moderate discomfort, and 4 for severe 
discomfort. The Mann-Whitney U test was used to assess these parameters; the lower the 
mean rank, the less discomfort the patient had experienced.  
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Patients in the Tisseel glue group experienced significantly less foreign body sensation and 
itchiness on the day after surgery, compared to the suture group, with a mean rank of 25.77 
versus 35.55 (p=0.038) for foreign body sensation and 25.98 versus 35.33 (p=0.018) for 
itchiness. Sensitivity to light and tearing showed no statistical difference between the two 
groups, with mean ranks of 27.42 versus 33.79 (p=0.620) and 26.84 versus 34.41 
(p=0.650), respectively.  
 
 
Figure 3.1: Level of comfort day 1 post-operatively 
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Similar results were seen at one-month follow-up, with patients in the Tisseel glue group 
experiencing less discomfort compared to the suture group. Foreign body sensation was 
statistically lower in the Tisseel glue group compared to the suture group, with a mean 
rank of 26.40 versus 34.60 (p=0.042), as also were sensitivity to light and itchiness with 
mean ranks of 24.12 versus 36.88 (p=0.001) and 26.43 versus 34.57 (p=0.009), 
respectively. The amount of tearing showed no statistical difference between the two 
groups, showing a mean rank of 29.00 versus 32.00 (p=0.232). 
 
 
Figure 3.2: Level of comfort 1 month post-operatively 
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At the three-month follow-up visit, there were no statistical differences between the two 
groups, when comparing foreign body sensation (mean rank 30.00 vs 31.00, p=0.317), 
sensitivity to light (mean rank 30.00 vs 31.00, p=0.317) and tearing (mean rank 29.50 vs 
31.50, p=0.154). However, the difference in discomfort attributed to itchiness between the 
two groups proved to be statistically significant, with mean ranks of 28.50 for Tisseel glue 
group and 32.50 for suture group (p=0.040). 
 
 
 Figure 3.3: Level of comfort 3 months post-operatively 
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Figure 3.4 demonstrates mean comfort scores over the three-month follow-up period in the 
Tisseel glue group. The lower the mean value, the less discomfort the patient experienced. 
When analysing, which dimension of discomfort was the most noticeable, Figure 3.4 
shows that foreign body sensation caused the most discomfort day-one, and one-month 
following surgery, when compared to sensitivity to light, tearing and itchiness.   
 
 
Figure 3.4: Tisseel glue group - changes in level of comfort on follow-up visits 
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The Figure 3.5 demonstrates mean comfort scores over the three-month follow-up period  
in the suture group. Foreign body sensation caused the most discomfort on day-one and 
one month following surgery. 
 
 
Figure 3.5: Suture group - changes in level of comfort on follow-up visits 
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Carlo Test was utilized to show any significant differences in comfort between the 
different grades of pterygia at all follow-up appointments. 
Day one following surgery, the mean ranks for foreign body sensation for grades I, II and 
III pterygia were: 26.72, 30.37 and 34.56 respectively (p=0.491); sensitivity to light: 27.22, 
32.39 and 30.15 respectively (p=0.560); tearing: 23.33, 31.33 and 34.38 respectively 
(p=0.249); and itchiness: 29.11, 32.02 and 29.88 respectively (p=0.828) [Figure3.6]. 
Therefore, on day-one following surgery, no significant differences between the level of 
comfort and pterygium size were noted.   
 
 
Figure 3.6: Grade of pterygium and level of comfort day 1 post-operatively 
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One month following surgery, the mean ranks for foreign body sensation for grades I, II 
and III pterygia were: 34.61, 30.85 and 27.62 respectively (p=0.570); sensitivity to light: 
32.33, 31.28 and 27.97 respectively (p=0.676); tearing: 27.00, 32.29 and 28.76 
respectively (p=0.285); and itchiness: 27.72, 29,79 and 33.38 respectively (p=0.469) 
[Figure 3.7]. This shows that one month following surgery, no significant difference 
between the level of comfort and pterygium size was shown. 
 
 
Figure 3.7: Grade of pterygium and level of comfort 1 month post-operatively 
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3.3  Graft Adherence 
Autograft success was defined as a graft that was still adherent and intact at the one-month 
follow-up visit. This study showed a 100% graft success in both groups of patients on day-
one, and at one and three-months follow-up. 
 
3.4  Recurrence  
Pterygium recurrences at three months were seen in seven patients (11.7%): four females 
and three males. Of these recurrences, four (6.7%) patients were from the Tisseel glue 
group and three (5%) from the suture group of the study. Due to the small study population 
of 60 patients and the few recurrences seen, Fischer’s Exact test was used to demonstrate 
that there was no statistically significant difference in the rates of pterygium recurrence 
between the Tisseel glue group and suture group. All the patients with recurrent pterygia 
were less than 40 years of age.  
 
3.5 Cost-Effectiveness 
In this study, the objective costs included Tisseel fibrin glue (Tisseel Kit 1.0H), suture 
material (vicryl 8-0), and theatre time. The subjective cost would be the patient’s level of 
comfort following the surgical procedure.  
 
3.5.1 Tisseel Glue and Suture Material  
Tisseel Kit 1H cost R1850 and was shared among four patients. This equated to a cost of 
R462.50 per patient if glue was used to secure the autograft.   
The alternative material in this study was vicryl 8-0 sutures single arm, at a cost of R204, 
which could only be used on one patient. Therefore, the cost of the product to secure the 
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autograft in the suture group was R204 per patient. Other consumables were used during 
the surgery; but these were consistent with both techniques; and therefore, would equally 
affect the costs of both procedures.  
 
3.5.2 Surgical Time 
The surgical time was recorded from the time the lid speculum was inserted into the eye to 
the time when the speculum was removed at the end of the surgical procedure. This was 
recorded on the data-capture sheet. The average surgical time for the Tisseel glue group 
was 7 minutes and 12 minutes for the suture group. Most institutions bill for every minute 
that the patient is in the operating room. The average theatre charges approximately R200 
per minute that the patient is in theatre. 
 
3.5.2 Surgical Time and Pterygium Size  
Pterygia were graded clinically (Table 1.1 Clinical grading system of pterygia and 
associated complications), according to how far they extend onto the cornea. In both the 
Tisseel glue group and the suture group, the numbers of grades I, II and III pterygia were 
unbalanced. Therefore, the Monte Carlo test was used to interpret whether the size of the 
pterygium impacted on the duration of the surgical procedure. In both the Tisseel glue 
group and suture groups, the size of the pterygium did not impact on the time of the 
procedure (p=0.076 and p=0.800, respectively). 
3.5.3 Patient Comfort 
Patients in the Tisseel glue group experienced significantly less foreign body sensation and 
itchiness on the day after surgery compared to the suture group. Similar results were seen 
at the one-month follow-up, with patients in the Tisseel glue group experiencing less 
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discomfort compared to the suture group. Foreign body sensation was significantly lower 
in the Tisseel glue group compared to the suture group, and there was less sensitivity to 
light and itchiness experienced by patients in the Tisseel glue group at this one-month 
follow-up visit. 
At the three-month follow-up visit, there was no statistical difference between the two 
groups, when comparing foreign body sensation, sensitivity to light and tearing. However, 
the difference in discomfort attributed to itchiness between the two groups proved to be 
statistically significant.  
Overall patients in the Tisseel glue group on day-one and one-month following surgery 
were more comfortable than those in the suture group.  
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CHAPTER 4 
DISCUSSION 
This study was conducted at the St John Eye Hospital, Soweto. This is the Ophthalmology 
Unit of the Division of Ophthalmology, Department of Neurosciences of the University of 
Witwatersrand situated adjacent to Chris Hani Baragwanath Academic Hospital. This is a 
referral centre for the greater Johannesburg area.  
During the period from April 2012 to September 2012, 60 patients were recruited for the 
study. The median age was 50 years, 42 (70%) were females, 18 (30%) were male and 56 
(93.3%) were black African patients. A female predominance was noted in this study. This 
finding was in contrast to a study undertaken in Alberton, Gauteng, which showed a male 
predominance in their 63 white patients with pterygia.9 This difference in gender 
predominance between these two studies may be due to the genetic and environmental 
differences in the two sample populations. 
Today, several methods for pterygium surgery are used – from bare scleral techniques to 
the use of medical and surgical adjunctives.11,21,25 Pterygium surgery is commonly 
performed in this institution, using vicryl sutures to secure the autograft. This technique 
requires a high level of surgical expertise, and also has several disadvantages. These 
include: prolonged surgery time, the possibility of suture-related complications, such as 
suture granulomas (mass of granulation tissue), abscess formation, tissue necrosis (cell 
death), giant papillary conjunctivitis; and importantly, the patient may complain post-
operatively of ocular irritation including foreign body sensation, pain, redness and 
itchiness.13,14 
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 An upregulation in the inflammatory response around vicryl sutures in the conjunctiva 
seems to be responsible for these adverse events.15 Therefore, by replacing the sutures with 
Tisseel fibrin glue; it would be expected that the graft would adhere and the post-operative 
discomfort and other complications associated with the suture material could well be 
alleviated.  
Tisseel fibrin glue is registered with the Medical Control Council (Appendix F) as a blood 
fraction, which is used to achieve haemostasis, to seal or glue tissues, and to support 
wound healing. The use of ocular tissue adhesives was proposed in 1963; and in the late 
1970s, fibrin adhesives became commercially available in Europe.18 Their use in 
Ophthalmology included conjunctival wound closure, cataract surgery, oculoplastic and 
orbital surgery, repair of leaking blebs, lamellar keratoplasty and amnion patching. The 
“cut-and-paste” method used by Koranyi et al. comprises the use of Tisseel tissue glue to 
secure the autograft; and it was developed to reduce post-operative patient discomfort, and 
to reduce surgical time.29 
Uy et al. later also found fibrin glue to be a safe and effective method for attaching 
autografts, as well as reducing surgical time and post-operative patient discomfort.14 And 
more recently, Nieuwendaal et al. reported the use of Tisseel glue to be a safe, easy and 
effective technique for attaching the autograft with low recurrence rates.17 There have been 
no studies prior to this one at St John eye Hospital regarding the use of adjunctives in 
pterygium surgery. The possibility of a safe, easy and effective surgical technique that 
could reduce patient discomfort, surgical time and costs in our institution was the driving 
force behind this prospective, randomized, comparative study.  
Pterygium excision was performed using the technique described by Starck et al.28 The 
autograft was adhered with either Tisseel fibrin glue or vicryl sutures. Overall, patients in 
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the Tisseel glue group on day-one and one-month following surgery were more 
comfortable than those in the suture group. The conclusion in this study that Tisseel glue 
significantly reduces post-operative discomfort is consistent with the literature.13,14,15,17,19,20  
The size or grade of a pterygium is related to the extent to which it encroaches on the 
cornea; and it was thereby assumed that the greater the surface area of cornea involved in 
the procedure, the greater the post-operative discomfort. However, in this study, the grade 
of the pterygium did not impact on the amount of post-operative discomfort at any of the 
follow-up appointments. This observation was also noted in a study by Bahar et al., where 
regression analysis failed to show any correlation between pterygium size and 
discomfort.20  
Koranyi et al. reported no autograft losses or dislocations in their study that compared glue 
and sutures to attach conjunctival autografts in pterygium excision surgery.29 In this study, 
autograft success was defined as a graft that was still adherent and intact at one-month 
follow-up. This study showed a 100% graft success in both groups of patients; and it 
highlights the fact that both techniques are effective for securing the autograft in pterygium 
excision surgery.  
Recurrence is a common complication of pterygium surgery; and the success of this 
surgery is based on avoiding this complication. Recurrence rates vary in the literature, 
based on the surgical expertise, the surgical technique, and the adjunctives used. 
Conjunctival autografting, regardless of the material used, following pterygium surgery has 
been associated with lower recurrence rates of 2% to 9 %.14 Hirst et al. reported a larger 
variability in recurrence rates of 2% to 39% when using glue-assisted conjunctival 
autografts.11 In this study, recurrence was seen in seven (11.7%) patients: four (6.7%) 
patients in the glue group, and three (5%) in the suture group. These recurrence rates are 
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consistent with the literature. However, the small sample size and the duration of the 
follow-up need to be taken into consideration when interpreting the data.  
When assessing the cost-effectiveness of a procedure, it is conventional to distinguish 
between the direct costs and the indirect or productivity costs, associated with the 
intervention, as well as what are termed intangibles, which, although they may be difficult 
to quantify, are often consequences of the intervention, and should therefore be included in 
the cost profile.27 
Direct Costs: Tisseel fibrin glue, sutures and theatre time. 
Productivity Costs: the longer the surgical time, the fewer the number of patients that can 
be operated on.  
Intangibles: Post-operative discomfort (foreign body sensation, tearing, itchiness, 
sensitivity to light)  
Using these simple definitions and equations, it was initially proposed in the protocol for 
this study that the following equation, Incremental Cost-Effective Ratios (ICER), could be 
used to calculate the cost-effectiveness of the different techniques.  
  Difference in costs between the 2 techniques   
ICER =    -------------------------------------------------------------------------     
      Difference in health effects between the 2 techniques    
Costs (numerator) would include the cost of Tisseel fibrin glue, sutures and theatre time; 
while health effects (denominator) would include post-operative comfort and graft 
adherence/success. However, retrospectively this is not something that statistics can do. 
This would involve an equation with various assumptions on how different variables 
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(objective elements, such as costs; and subjective factors, such as patient comfort) should 
be weighted, which is beyond the scope of this study.  
Rather, each element should be evaluated separately, without combining them into a single 
best-measure, which would require some form of arbitrary weighting.  Therefore, cost 
effectiveness could not be accurately assessed in this study; however, subjective and 
objective costs could be compared in a simplified manner. The subjective cost would be 
the patient’s level of comfort following the procedure; while the objective costs would 
include Tisseel fibrin glue (Tisseel Kit 1.0H), suture material (vicryl 8-0), and theatre time.  
As already mentioned, patients in the Tisseel glue group experienced significantly less 
post-operative discomfort on follow-up when compared with the suture group, which could 
translate into a reduced subjective cost. Tisseel Kit 1H cost R1850 and the product could 
be shared between four and ten patients over a period of 4 hours from the time of glue 
preparation. It would be ideal to operate on ten consecutive patients, in order to reduce 
material costs; however, this is not always possible; as either there may be too few patients 
booked on the list, or there would be a need to use the theatre for more urgent surgeries. In 
this study, the Tisseel glue was shared among four patients. This equates to a cost of 
R462.50 per patient to use glue to secure the autograft. 
The alternative material in this study was vicryl 8-0 sutures single arm at a cost of R204, 
which could only be used for one patient. Therefore, the cost of the product to secure the 
autograft in the suture group was R204 per patient. Other consumables were used during 
the surgery; but these are consistent with both techniques; and therefore, would equally 
affect the cost of both procedures. This demonstrates how objective costs can be reduced if 
Tisseel glue is shared amongst several patients.  
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The average surgical time for the Tisseel glue group was 7 minutes, and 12 minutes for the 
suture group. This compares to Bahar et al. who in their study reported a mean operating 
time of 16 minutes in the fibrin-glue group and 20 minutes in the suture group.20 As 
previously noted, pterygia were graded, based on the size of the growth. In both the Tisseel 
glue group and suture groups, the size of the pterygium did not impact on the time of the 
procedure. Bahar et al. also failed to show any correlation between pterygium size and 
surgery time.20  Most institutions bill per minute that the patient is in the operating room. 
Therefore, the shorter the procedure, the less costly it is. The average private institution 
charges approximately R200 per minute that the patient is in theatre. It follows that using 
Tisseel glue to secure the autograft would reduce this objective cost.   
This prospective, randomized comparative study was small in size, and not double-blinded, 
which could have impacted on the statistical analysis. The evaluation of discomfort was 
expected to be problematic, as patients may have had variable sensitivities to the same 
stimulus; and they would, therefore, have reported their experience and level of discomfort 
differently. However, by categorizing discomfort into four simple dimensions, this 
variability in reporting was most probably limited.  
 Of the 60 patients treated, 56 (93.3%) were black African patients. A census in 2011 
reported that Soweto has a population of 1,271 628 million people; and 98.54 % were 
black Africans.30 This shows that the sample population was a good reflection of the 
demographics of patients in this area; and that the surgical recommendations from this 
study could be used for patients at this institution and surrounding areas. Perhaps a study 
that included another region of South Africa, with different population demographics, 
might be useful in comparing these two surgical techniques 
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CHAPTER 5 
CONCLUSION 
This comparison of the use of Tisseel fibrin glue and vicryl sutures in pterygium excision 
surgery showed that patients post-operatively in the Tisseel glue group were significantly 
more comfortable than those in the suture group. Graft success was documented in all 
patients of both surgical groups. Tisseel fibrin glue is, therefore, considered an effective 
method for attaching conjunctival autografts; and it also offers the benefit of less post-
operative discomfort, shorter operating times, and reduced overall costs for the procedure.  
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APPENDICES 
Appendix A: Information Sheet 
Translations into your language of preference may be carried out by Sister Tshabalala, St 
John Eye Hospital. 
A Comparison of Fibrin Glue with Sutures For Conjunctival Autografts In Pterygium 
Excision Surgery 
Good day, my name is Dr Lara Sandri and I am specializing in eye surgery in the 
Department of Ophthalmology at the University of the Witwatersrand. As part of my 
training, I am required to do research in this field. Research is a process where we try and 
learn more about a question we don’t have the answer for. 
A pterygium is a triangular growth on the surface of the eye; and it is very common in our 
country. They are usually red and painful, and can affect your vision. It is believed that 
these growths are caused by exposure to high levels of ultraviolet -B rays from the sun, 
hot, dry and dusty climates; and they may possibly have a genetic component as well. It is 
believed that wearing a large hat and sunglasses when spending extended hours in the sun 
may prevent this condition in patients who are at risk of developing a pterygium. However, 
if a pterygium is present, most of these growths require an operation to remove them from 
the surface of the eye. You have been identified as having this growth on your eye; and I, 
therefore, ask you to consider the following invitation. 
This is an invitation to participate in my study that will be carried out at St John Eye 
Hospital. 
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The study will involve the standard surgical procedure of removing this growth from your 
eye. During this procedure, the growth is removed superficially from the eye; and the bare 
area left behind is covered with a small piece of tissue (conjunctival graft). This 
conjunctiva lines the surface of the white part of your eye known as the sclera. A very 
small piece is taken from a different area on the same eye; and this is then used to cover 
the bare area where the mass was excised. At this point, this tissue is known as a graft; and 
it needs to be secured to the surrounding tissue. The study will be comparing two 
techniques, which are routinely used to secure this graft, namely: stitches and glue. The 
glue is a natural fibrin glue known as Tisseel; while the stitches are dissolving stitches. 
Both techniques are practised throughout the world, and have been proven to be safe and 
effective.  
The reason why I have chosen this study is that I want to investigate which one of the 
techniques leaves you with less pain after the operation, and still keeps that area closed 
(allows the graft to stick). Regardless of which material is to be used on your eye, both are 
regarded as standard practice, and are considered safe and effective. 
If you decide to take part in this study, you will be allocated randomly to one of the two 
groups, and receive either the glue or stitches during the surgery. The surgery will take 
place at St John Eye Hospital under local anaesthetic (numbing injection around the eye). 
During the procedure, you will be awake, but will have no pain at all. The operating time 
may vary between 16-40 minutes, depending on which technique is performed.  
All the tissue that is removed will be sent for routine examination at our laboratory; and the 
results will be given to you at your follow-up visits. Standard follow-up includes an 
examination the day after the operation, as well as 1 month and 3 months, thereafter. On 
each follow-up visit, a brief routine examination will be carried out; and it would be 
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appreciated if a few questions regarding your level of comfort could be answered. These 
questions will include descriptions of how your eye feels; and they will be very brief. After 
each consultation, the necessary eye drops/medications will be supplied to you at no extra 
cost. If you are unable to attend these appointments, I would like your permission to 
contact you telephonically, so that another time can be rescheduled or another arrangement 
made. 
Pterygium surgery is carried out frequently at most eye centres worldwide; and it is well 
reported on in textbooks and articles. Most surgical procedures come with risks or 
complications; fortunately for this surgery, these are minimal. Complications for this 
procedure usually refer to whether the graft has remained stuck down or not, and whether 
the pterygium has grown back.  
Complications of the suture material include allergic irritation and the formation of a bump 
at the surgical site; but these are uncommon. Some ingredients of the glue are made of 
animal products; and this carries with it an incredibly small risk of infection. Many of you 
may have had this surgery on the other eye before; and you will have an understanding of 
the procedure and the post-operative period. 
The benefits of being included in this study include the following: 
• Patient’s eyes in one of the group may experience less pain post-operatively; 
• The technique with a shorter surgical time may be identified;  
• It may have a large impact on the number of pterygium surgeries performed at our 
institution; as one technique appears to be far less time-consuming. This will 
facilitate a higher turnover and a shorter waiting list for patients; 
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• One technique may be more cost-effective, thereby allowing a larger number of 
patients to be operated on; 
• If abnormal results are found on the analysis of the tissue, these will be managed 
appropriately. 
 
Other treatments for this condition include: moisturizing eye drops; however, this is only a 
temporary measure; and  usually surgery alone is needed. 
During and after the study, your identity will remain confidential, which means that all 
your personal details will not be shared. Your name will be assigned a study code, under 
which all your demographics, surgery details, examination findings and responses to 
questions will be collected. This information without your name will be seen by me, the 
statistician, and the medical fraternity (both national and international).  
If at any point you choose to withdraw from this study, you may do so immediately, and 
without reason or consequence; and your withdrawal will not impact on your future health 
care at our facility. 
Contact details of researcher: 
For further information, feel free to contact 
me on the following numbers 
REC Administrator and Chair  
The study has been approved by the Wits 
HREC (Medical). Any queries or questions  
regarding your right as a research 
participant please contact 
Lara Sandri   
(011) 933 9771 / (011) 463 0406 
Prof. Peter Cleaton-Jones/ Anisa Keshav  
(011) 717 1234 
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Appendix B: Informed Consent  
I, ___________________________________________, the undersigned hereby consent to 
voluntarily participate in this study. Dr Lara Sandri has clearly informed me and pointed 
out the purposes of the research she will be conducting. I have read and understand the 
information sheet provided to me, which clearly explains the procedure and its risks. 
• I am aware that I do have the right not to participate or to discontinue participation 
at any time, without prejudicing any treatment that is required for existing or future 
medical conditions.   
• Patient confidentiality will be maintained at all times, meaning that information 
may be used from my file, as long as my name is not mentioned. 
• The documents completed by Dr Sandri are the only records that will be used for 
data collection. 
• If I have any queries, they will be directed accordingly. 
ENROLLED PATIENT 
_____________________  ________________  ________________ 
Full name and Surname   Date           Signature   
STUDY DOCTOR: 
I, Dr Lara Sandri, hereby confirm that I have fully informed the participating patient of the 
nature and purposes of my study. 
_____________________  ________________  ________________ 
Full name and Surname   Date           Signature  
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Appendix C: Data-Capturing Sheet 
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Appendix D: Ethics Certificate 
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Appendix E:  Letter For Permission To Conduct Research 
 
	   	  52	  
Appendix F: Medical Control Council Registration of Tisseel 
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Appendix G: Sponsorship Certificate from Adcock Ingram  
 
30 August 2011 
 
ST JOHN’S EYE HOSPITAL 
 
Att: Dr Lara Sandri 
 
REQUEST FOR DONATION OF TISSEEL  
 
Adcock Ingram Critical Care will sponsor the Tisseel required for your research project on 
Pterygium Surgery using a fibrin glue vs sutures. 
Please contact me should you require further information. 
Kind Regards, 
 
 
 
AUDREY ANTHONY 
Product Manager 
Medicine Delivery 
Tel: 011 494 8745 
Cell: 082 561 5325 
